KalVista Pharmaceuticals Inc Forecast and Stock Analysis
Technical KALV stock analysis for Wednesday June 19, 2019.
KalVista Pharmaceuticals Inc gained 0.20% in the last trading day ( Wednesday, 19th Jun 2019 ), rising from $20.41 to $20.45 During day the stock fluctuated 3.04% from a day low at $19.90 to a day high of $20.51. The price has risen in 6 of the last 10 days and is up by 5.47% over the past 2 weeks. Volume fell in the last day by -12 159 shares, and in total, 82 945 shares bought and sold for approximately $1.70 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the KALV stock price was $24.35 and low was $18.05.
- 90 day high was $32.15 and low was $18.05.
- 52 week high for the KalVista Pharmaceuticals Inc - $34.92 and low - $7.85.
KalVista Pharmaceuticals Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -31.02% during the next 3 months and, with 90% probability hold a price between $11.66 and $15.46 at the end of this period.
Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. KalVista Pharmaceuticals Inc holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $21.99. On a fall, the stock will find some support from the short-term average at $19.83. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Monday June 17, 2019, which indicates further falls until a new bottom pivot has been found.
Relative Strength Index (RSI)
RSI14 is 37 and the stock is currently not being overbought or oversold
Support & Resistance
KalVista Pharmaceuticals Inc finds support from accumulated volume at $20.21.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.61 between high and low, or 3.04%. For the last week, the stock has had a daily average volatility of 4.85%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
4.85 %Average volatility
Very Low Low Medium High Very High
KalVista Pharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|KALV $20.45 ($0.04 0.20%)|
KALV is up $0.04 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for KALV based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the KALV analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us